NASDAQ
Aethlon Medical, Inc. (AEMD) has a free cash flow growth of -13.10% as of Friday, May 29, 2026. This represents a 99.95% increase compared to its 12-month average of -25609.18%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.